drugset / Trial / NCT00745771

Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

NCT00745771

Phase 2 Completed 168 enrolled IDEA AG
Treatment

Summary

Multiple-dose, double-blind, double-dummy, parallel, randomized, placebo and active controlled study of pharmacokinetics of Diractin® as well as safety and efficacy for muscle soreness from exercise.

Timeline

Start
2007-10
Primary completion
2008-02
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketoprofen Small molecule 100 mg
Comparator Ketoprofen Small molecule 200 mg

Indications

No indication recorded.